EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers

Epstein-Barr virus (EBV) infects more than 90% of humans worldwide and establishes lifelong latent infection in the hosts. It is closely associated with endemic forms of a wide range of human cancers and directly contributes to the formation of some. Despite its critical role in cancer development,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lijun, Xie, Chen, Lung, Hong Lok, Lo, Kwok Wai, Law, Ga-Lai, Mak, Nai-Ki, Wong, Ka-Leung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276081/
https://www.ncbi.nlm.nih.gov/pubmed/30555548
http://dx.doi.org/10.7150/thno.26823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276081/
https://www.ncbi.nlm.nih.gov/pubmed/30555548
http://dx.doi.org/10.7150/thno.26823

Ejemplares similares